Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?Daniela De Benedittis, Roberto Latagliata, Massimo Breccia et al.|Blood|2018Cited by 0
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center CohortSofia Chiatamone Ricci, Antonietta Ferretti, Massimo Breccia et al.|Blood|2018Cited by 0